scispace - formally typeset
Open AccessJournal ArticleDOI

Transplanted dopaminergic neurons: more or less?

About
This article is published in Nature Medicine.The article was published on 2001-05-01 and is currently open access. It has received 41 citations till now. The article focuses on the topics: Dopaminergic.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells.

TL;DR: It is concluded that biodegradable polymer/progenitor cell composite grafts provide an effective means of increasing progenitor cell survival and overall yield when transplanting to sites within the central nervous system such as the retina.
Journal ArticleDOI

Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space

TL;DR: Ultra-thin film PMMA scaffolds micromachined to contain through pores retain adherent RPCs to a considerably greater extent than unmachined versions during the transplantation process and can serve as a biocompatible substrate for cell delivery in vivo.
Journal ArticleDOI

Tauroursodeoxycholic Acid Improves the Survival and Function of Nigral Transplants in a Rat Model of Parkinson's Disease:

TL;DR: It is demonstrated that pretreatment of the cell suspension with TUDCA can reduce apoptosis and increase the survival of grafted cells, resulting in an improvement of behavioral recovery.
Journal ArticleDOI

Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke

TL;DR: A proof-of-concept "retroviral" strategy is explored to further establish the post-mitotic status of NT2N cells by transfecting these cells with the transcription factor Nurr1, in addition to the standard treatment with retinoic acid and mitotic inhibitors.
References
More filters
Journal ArticleDOI

Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

TL;DR: After improvement in the first year, dystonia and dyskinesias recurred in 15 percent of the patients who received transplants, even after reduction or discontinuation of the dose of levodopa.

Transplantation of embryonic dopamine neurons for severe parkinson's disease

TL;DR: For example, in this paper, the authors randomly assigned 40 patients who were 34 to 75 years of age and had severe Parkinson's disease (mean duration, 14 years) to receive a transplant of nerve cells or undergo sham surgery; all were to be followed in a double-blind manner for one year.
Related Papers (5)